Cypress Capital Group Aflac Inc Transaction History

Cypress Capital Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$75.43 - $84.35 $31,303 - $35,005	415 Added 6.54%	6,758 $557,000
Q3 2023 Nov 02, 2023	BUY	$69.57 - $77.95 $45,011 - $50,433	647 Added 11.36%	6,343 $486,000
Q2 2023 Jul 26, 2023	BUY	$63.91 - $70.36 $364,031 - $400,770	5,696 New	5,696 $397,000
Q2 2022 Jul 26, 2022	SELL	$53.01 - $66.62 $264,042 - $331,834	-4,981 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$58.27 - $66.04 $16,315 - $18,491	280 Added 5.96%	4,981 $321,000
Q4 2021 Feb 15, 2022	BUY	$52.77 - $58.79 $248,071 - $276,371	4,701 New	4,701 $274,000

1,698

372M

4.13M

2.31M

Ticker AFL
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 631,916,032
Market Cap $71B
Description
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving ...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.